C

LeMaitre Vascular, Inc. LMAT

$82.59 -$0.30-0.36% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

LeMaitre Vascular, Inc. is a U.S.-based medical device company focused on the development, manufacture, and marketing of products used primarily in the treatment of peripheral vascular disease and related conditions. The company operates within the broader vascular surgery and cardiovascular medical technology industries, serving hospitals, vascular surgeons, cardiovascular surgeons, and interventional specialists. Its product portfolio includes vascular grafts, biologic patches, carotid shunts, valvulotomes, embolectomy catheters, surgical sealants, and devices used in open vascular surgery procedures. Revenue is primarily generated through direct product sales to healthcare providers and distributors across multiple international markets.

LeMaitre Vascular has positioned itself as a specialized provider in niche vascular surgery markets that are often underserved by larger diversified medical device manufacturers. The company emphasizes surgeon-focused product development, targeted acquisitions, and direct sales infrastructure. Founded in 1983 by vascular surgeon Dr. George LeMaitre, the company initially concentrated on devices supporting vascular surgical procedures and later expanded through acquisitions and internal product innovation. Over time, it evolved into a global vascular device company with a portfolio spanning biologic implants, vascular access products, and surgical tools.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range11% of range
Low
$78.22
Current
$82.59
High
$118.01
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
781 221 2266
Address
63 Second Avenue
Burlington, MA 01803
Country
Year Founded

Headlines